Dr. Jakub Tolar to Speak at Gene Therapy for Rare Diseases Symposium

March 3, 2017

Dr. Jakub Tolar, Executive Vice Dean, will be speaking at the New York Academy of Sciences for their one-day symposium, Gene Therapy for Rare Diseases. Many life-threatening rare diseases are due to a single gene mutation. Often, there are no effective treatment options, and affected children require constant, life-long, expensive care. Gene therapy shows promise as a clinical strategy for these disorders, and work is in progress to address the challenges of delivering safe, consistent, and durable gene therapy to targeted tissues. This symposium will explore recent advances, identify remaining issues to be addressed, and explore opportunities for the application of gene therapy to more common diseases.

Gene Therapy for Rare Diseases

Tuesday, April 11, 2017 | 9:00 AM - 5:00 PM

The New York Academy of Sciences

Share this post

You may also like:

“When we think about viruses, we think disease,” says Masato Yamamoto, M.D., Ph.D., a professor in the Department of Surgery and member of the Masonic Cancer Center, University of Minnesota. “But by wisely using viruses, we can design therapies that target cancer cells.”